AEGiS-MMWR: APPENDIX A. Practice Recommendations for Health-Care Facilities Implementing the U.S. Public Health Service Guidelines for Management of Occupational Exposures to Bloodborne Pathogens

Important note: Information in this article was accurate in June 2001. The state of the art may have changed since the publication date.

APPENDIX A. Practice Recommendations for Health-Care Facilities Implementing the U.S. Public Health Service Guidelines for Management of Occupational Exposures to Bloodborne Pathogens

Morbidity and Mortality Weekly Report, June 29, 2001 / 50(RR11);43-4
Centers for Disease Control and Prevention

Practice recommendation	Implementation checklist
Establish a bloodborne pathogen policy.	All institutions where health-care personnel (HCP) might experience exposures should have a written policy for management of exposures.
	The policy should be based on the U.S. Public Health Service (PHS) guidelines.
	The policy should be reviewed periodically to ensure that it is consistent with PHS recommendations.
Implement management policies.	Health-care facilities (HCF) should provide appropriate training to all personnel on the prevention of and response to occupational exposures.
	HCF should establish hepatitis B vaccination programs.
	HCF should establish exposure-reporting systems.
	HCF should have personnel who can manage an exposure readily available at all hours of the day.
	HCF should have ready access to postexposure prophylaxis (PEP) for use by exposed personnel as necessary.
Establish laboratory capacity for bloodborne pathogen testing.	HCF should provide prompt processing of exposed person and source person specimens to guide management of occupational exposures.
	Testing should be performed with appropriate counseling and consent.

Practice recommendation	Implementation checklist
Select and use appropriate PEP regimens.	HCF should develop a policy for the selection and use of PEP antiretroviral regimens for HIV exposures within their institution.
	Hepatitis B vaccine and HBIG should be available for timely administration.
	HCF should have access to resources with expertise in the selection and use of PEP.
Provide access to counseling for exposed HCP.	HCF should provide counseling for HCP who might need help dealing with the emotional effect of an exposure.
	HCF should provide medication adherence counsel ing to assist HCP in completing HIV PEP as necessary.
Monitor for adverse effects of PEP.	HCP taking antiretroviral PEP should be monitored periodically for adverse effects of PEP through baseline and testing (every 2 weeks) and clinical evaluation.
Monitor for seroconversion.	HCF should develop a system to encourage exposed HCP to return for follow-up testing.
	Exposed HCP should be tested for HCV and HIV.
Monitor exposure management programs.	HCF should develop a system to monitor reporting and management of occupational exposures to ensure timely and appropriate response.
	Evaluate exposure reports for completeness and accuracy, access to care (i.e., the time of exposure to the time of evaluation), and laboratory result reporting time.
	Review exposures to ensure that HCP exposed to sources not infected with bloodborne pathogens do not receive PEP or that PEP is stopped.
	Monitor completion rates of HBV vaccination and HIV PEP and completion of exposure follow-up.

Disclaimer All MMWR HTML versions of articles are electronic conversions from ASCII text into HTML. This conversion may have resulted in character translation or format errors in the HTML version. Users should not rely on this HTML document, but are referred to the electronic PDF version and/or the original MMWR paper copy for the official text, figures, and tables. An original paper copy of this issue can be obtained from the Superintendent of Documents, U.S. Government Printing Office (GPO), Washington, DC 20402-9371; telephone: (202) 512-1800. Contact GPO for current prices.

NOTE: MMWR's are in Portable Document Format (PDF) to retain the original format. To view or print these documents, you must use the Adobe Acrobat viewer. Acrobat is free and available directly from Adobe's website with full installation instructions.

Download RR5011

010629
RR5011a2

AEGiS is made possible through unrestricted grants from Boehringer Ingelheim, iMetrikus, Inc., the National Library of Medicine, and donations from users like you. Always watch for outdated information. This article first appeared in 2000. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1990, 2000. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content.